CatSci Ltd is an award-winning innovation partner, dedicated to breaking down the silos in small molecule, and oligonucleotide drug development to accelerate the delivery of life-changing medicines to patients in need. We proudly serve customers worldwide, overcoming development challenges from candidate selection through product launch, and beyond. Our early development services include route scouting and selection, initial scale-up, and risk management. For later development, we provide process design, assessment, optimization, scale-up for clinical and commercial manufacture, tech transfer, and post-approval improvements. We possess a range of critical enabling technologies including catalysis, solid state science, preformulation, GMP-analytical development, and HPAPI development.